Leadership
GBM AGILE
About GBM AGILE
GBM AGILE Trial Sites
FAQs
Strategic Partners
REMAP-COVID
About REMAP-COVID
News
Join Us
Contact
DONATE
< Back to News
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
FEBRUARY 25, 2021 | NEJM
https://www.nejm.org/doi/full/10.1056/NEJMoa2100433?query=featured_home
Home
Leadership
About REMAP-COVID
GBM AGILE
About GBM AGILE
GBM AGILE Trial Sites
FAQs
Strategic Partners
News
Join Us
Contact
DONATE